Phase II trial of 5-fluorouracil/leucovorin/gemcitabine/cisplatin as second-line treatment in patients with metastatic or recurrent colorectal carcinoma: A cancer therapeutics research group study

Alex Y. Chang, Gilberto Lopes, Wen Hsin Koo, Robert Lim, Kian Fong Foo, John Wong

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of 5-fluorouracil/leucovorin/gemcitabine/cisplatin as second-line treatment in patients with metastatic or recurrent colorectal carcinoma: A cancer therapeutics research group study'. Together they form a unique fingerprint.

Medicine & Life Sciences